Contrast-Enhanced Radiotherapy With GM-CSF Immune Stimulation - Phase I/II Clinical Center Treatment Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Sargramostim (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Apr 2013 New trial record
- 26 Mar 2013 Biomarkers information updated